At the news
? BULLISHIMPACT 4/10 PRESS-RELEASE filed Sep 16, 2026 at 06:30 ET
Medtronic announced FDA clearance for the LigaSure RAS Maryland jaw device on its Hugo RAS system, expanding the instrument portfolio for robotic-assisted surgery in the U.S. This is an incremental product clearance that adds a trusted vessel-sealing tool to the Hugo platform, which is currently cleared only for urologic procedures in the U.S. The news is positive but modest for a $119.9B diversified medtech company, as it represents a line extension rather than a transformative catalyst.
- FDA cleared LigaSure RAS Maryland jaw device for use with Hugo RAS system in the U.S.
- LigaSure technology has been used in over 45 million surgical procedures worldwide across 65+ countries.
- Hugo RAS system is currently cleared only for urologic surgical procedures in the U.S.; Medtronic is pursuing expansion to general and gynecologic procedures.
- The LigaSure RAS Maryland instrument was introduced on the Hugo RAS system in Europe in 2025 after CE Mark.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access